Selective p300 degradation via peptide PROTAC: a new therapeutic strategy for advanced prostate cancers.

EBioMedicine

Department of Biochemistry and Molecular Biology, Chang Gung University, Taoyuan 33302, Taiwan; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan 33305, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292422PMC
http://dx.doi.org/10.1016/j.ebiom.2024.105245DOI Listing

Publication Analysis

Top Keywords

selective p300
4
p300 degradation
4
degradation peptide
4
peptide protac
4
protac therapeutic
4
therapeutic strategy
4
strategy advanced
4
advanced prostate
4
prostate cancers
4
selective
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!